TR199800398T1 - Tazefelonun alternatif kristal bi�imi. - Google Patents
Tazefelonun alternatif kristal bi�imi.Info
- Publication number
- TR199800398T1 TR199800398T1 TR1998/00398T TR9800398T TR199800398T1 TR 199800398 T1 TR199800398 T1 TR 199800398T1 TR 1998/00398 T TR1998/00398 T TR 1998/00398T TR 9800398 T TR9800398 T TR 9800398T TR 199800398 T1 TR199800398 T1 TR 199800398T1
- Authority
- TR
- Turkey
- Prior art keywords
- tazefelon
- crystal form
- alternative crystal
- alternative
- freshfelon
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 208000013016 Hypoglycemia Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US335695P | 1995-09-07 | 1995-09-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR199800398T1 true TR199800398T1 (xx) | 1998-05-21 |
Family
ID=21705475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR1998/00398T TR199800398T1 (xx) | 1995-09-07 | 1996-09-03 | Tazefelonun alternatif kristal bi�imi. |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0761656B1 (OSRAM) |
| JP (1) | JPH11514978A (OSRAM) |
| KR (1) | KR19990044453A (OSRAM) |
| CN (1) | CN1082958C (OSRAM) |
| AR (2) | AR003484A1 (OSRAM) |
| AT (1) | ATE198476T1 (OSRAM) |
| AU (1) | AU716684B2 (OSRAM) |
| BR (1) | BR9610201A (OSRAM) |
| CA (1) | CA2231132A1 (OSRAM) |
| CO (1) | CO4750653A1 (OSRAM) |
| CZ (1) | CZ68098A3 (OSRAM) |
| DE (1) | DE69611407T2 (OSRAM) |
| DK (1) | DK0761656T3 (OSRAM) |
| EA (1) | EA000258B1 (OSRAM) |
| ES (1) | ES2153081T3 (OSRAM) |
| GR (1) | GR3035656T3 (OSRAM) |
| HU (1) | HUP9901458A3 (OSRAM) |
| IN (1) | IN182320B (OSRAM) |
| MY (1) | MY132351A (OSRAM) |
| NO (1) | NO309719B1 (OSRAM) |
| NZ (1) | NZ316810A (OSRAM) |
| PE (1) | PE23298A1 (OSRAM) |
| PL (1) | PL325602A1 (OSRAM) |
| PT (1) | PT761656E (OSRAM) |
| SI (1) | SI0761656T1 (OSRAM) |
| TR (1) | TR199800398T1 (OSRAM) |
| TW (1) | TW460471B (OSRAM) |
| WO (1) | WO1997009320A1 (OSRAM) |
| ZA (1) | ZA967422B (OSRAM) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US538690A (en) * | 1895-05-07 | Automatic watering-trough for animals | ||
| US5216002A (en) * | 1989-12-21 | 1993-06-01 | Eli Lilly And Company | Method of treating inflammatory bowel disease |
| IL96654A (en) * | 1989-12-21 | 1995-06-29 | Lilly Co Eli | Hydroxybenzyl substituted sulfur containing heterocyclic derivatives their preparation and pharmaceutical compositions containing them |
-
1996
- 1996-09-02 PE PE1996000641A patent/PE23298A1/es not_active Application Discontinuation
- 1996-09-02 AR ARP960104199A patent/AR003484A1/es not_active Application Discontinuation
- 1996-09-02 IN IN1563CA1996 patent/IN182320B/en unknown
- 1996-09-02 DE DE69611407T patent/DE69611407T2/de not_active Expired - Fee Related
- 1996-09-02 AT AT96306336T patent/ATE198476T1/de not_active IP Right Cessation
- 1996-09-02 DK DK96306336T patent/DK0761656T3/da active
- 1996-09-02 EP EP96306336A patent/EP0761656B1/en not_active Expired - Lifetime
- 1996-09-02 SI SI9630287T patent/SI0761656T1/xx unknown
- 1996-09-02 ZA ZA9607422A patent/ZA967422B/xx unknown
- 1996-09-02 AR ARP960104198A patent/AR003483A1/es not_active Application Discontinuation
- 1996-09-02 ES ES96306336T patent/ES2153081T3/es not_active Expired - Lifetime
- 1996-09-02 TW TW085110670A patent/TW460471B/zh active
- 1996-09-02 PT PT96306336T patent/PT761656E/pt unknown
- 1996-09-03 KR KR1019980701701A patent/KR19990044453A/ko not_active Withdrawn
- 1996-09-03 JP JP9511339A patent/JPH11514978A/ja active Pending
- 1996-09-03 NZ NZ316810A patent/NZ316810A/xx unknown
- 1996-09-03 CA CA002231132A patent/CA2231132A1/en not_active Abandoned
- 1996-09-03 BR BR9610201A patent/BR9610201A/pt not_active Application Discontinuation
- 1996-09-03 HU HU9901458A patent/HUP9901458A3/hu unknown
- 1996-09-03 AU AU69127/96A patent/AU716684B2/en not_active Ceased
- 1996-09-03 EA EA199800275A patent/EA000258B1/ru not_active IP Right Cessation
- 1996-09-03 WO PCT/US1996/014132 patent/WO1997009320A1/en not_active Ceased
- 1996-09-03 CZ CZ98680A patent/CZ68098A3/cs unknown
- 1996-09-03 CN CN96197822A patent/CN1082958C/zh not_active Expired - Fee Related
- 1996-09-03 TR TR1998/00398T patent/TR199800398T1/xx unknown
- 1996-09-03 PL PL96325602A patent/PL325602A1/xx unknown
- 1996-09-04 MY MYPI96003663A patent/MY132351A/en unknown
- 1996-09-05 CO CO96047346A patent/CO4750653A1/es unknown
-
1998
- 1998-03-03 NO NO980913A patent/NO309719B1/no not_active IP Right Cessation
-
2001
- 2001-03-29 GR GR20010400506T patent/GR3035656T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE152910T1 (de) | Verwendung von taxol zur herstellung eines arzneimittels zur behandlung von krebs | |
| ZM489A1 (en) | Chemical compounds | |
| IL111077A (en) | Pyridine derivatives processes for the preparation thereof and pharmaceutical compositions containing them | |
| GB8829556D0 (en) | New cyclosporin crystal form processes for its production pharmaceutical compositions containing it and its use | |
| PL346520A1 (en) | Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase | |
| ES8301979A2 (es) | Mejoras en el objeto de la patente de invencion n.487.721 por procedimiento de preparacion de nuevos derivados del nortropano. | |
| IL55423A (en) | 3,4,5-trihydroxypiperidine compounds,their production and pharmaceutical compositions containing them | |
| IL116385A (en) | Sulphonamides their manufacture and pharmaceutical compositions containing them | |
| ES8106720A1 (es) | Un procedimiento para la preparacion de diariltiofenos. | |
| TR199903213T2 (xx) | Pirimidin-2,4,6-trion t�revleri, bunlar�n �retimi i�in i�lemler ve bu bile�ikleri ihtiva eden farmas�tik preparasyonlar. | |
| TW268937B (OSRAM) | ||
| ATE196083T1 (de) | Verwendung von ferrioxamin-b zur behandlung septischen schocks | |
| TR199802042T2 (xx) | Yeni karbon asidi t�revleri, �retimleri ve kullan�mlar�. | |
| PT76247B (en) | Process for preparing antiinflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes and of pharmaceutical compositions containing the same | |
| RU94000064A (ru) | Новые 2-циано-3-гидроксипропенамиды, метод их получения и содержащие их фармацевтические композиции | |
| IL56072A0 (en) | Novel biological substance obtained from a fugus, its production and pharmaceutical compositions containing it | |
| ES2128313T3 (es) | Naftalimidas n-substituidas, su obtencion y empleo. | |
| MX9801705A (es) | Forma de cristal alterno de la tazofelona. | |
| EP0386920A3 (en) | 2-hydroxy-3-thienyloxypropylamino derivatives | |
| DE69421531D1 (de) | Verwendung von rosmanolderivaten zur herstellung von antiradikalischen und/oder antilipoperoxidativen und/oder hepatotropen arzneistoffen | |
| ZA889540B (en) | New cyclosporin crystal form,processes for its production,pharmaceutical compositions containing it and its use | |
| ATE230267T1 (de) | Zusammensetzungen enthaltend vx478, zidovudine und 159u89 für die verwendung in der behandlung von hiv | |
| ES475960A1 (es) | Procedimiento para la preparacion de 3-di-n-propil-acetoxi- venzodiazepin-2-onas. | |
| HU901588D0 (en) | Process for the preparation of organic platinum complexes and pharmaceutical compositions containing them | |
| ATE87314T1 (de) | Platin-arzneimittel. |